Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 39,517 | 36,552 | 33,896 | 31,235 | 28,121 |
| Cost of Goods | 8,301 | 7,891 | 7,827 | 7,311 | 7,140 |
| Gross Profit | 31,216 | 28,661 | 26,069 | 23,924 | 20,981 |
| Operating Expenses | 32,050 | 33,494 | 31,508 | 26,887 | 24,421 |
| Operating Income | -533 | -3,942 | -4,612 | -2,652 | -3,300 |
| Interest Expense | 22 | 34 | 51 | 56 | 91 |
| Other Income | 116 | 213 | 249 | 313 | 369 |
| Pre-tax Income | -439 | -3,763 | -4,414 | -2,395 | -3,022 |
| Income Tax | 63 | 180 | 210 | N/A | N/A |
| Net Income Continuous | -502 | -3,943 | -4,624 | -2,334 | -3,022 |
| Net Income | $-502 | $-3,943 | $-4,624 | $-2,334 | $-3,022 |
| EPS Basic Total Ops | -0.02 | -0.14 | -0.16 | -0.07 | -0.11 |
| EPS Basic Continuous Ops | -0.02 | -0.14 | -0.16 | -0.08 | -0.11 |
| EPS Diluted Total Ops | -0.02 | -0.14 | -0.16 | -0.07 | -0.11 |
| EPS Diluted Continuous Ops | -0.02 | -0.14 | -0.16 | -0.08 | -0.11 |
| EBITDA(a) | $1,160 | $-2,357 | $-3,022 | $-1,230 | $-1,930 |